Tag: Weight Loss
FDA Creates ‘Green List’ of GLP-1 Drug Ingredients Approved for Entry in the U.S.
The purpose of the list is to keep unverified and unapproved GLP-1 drug ingredients from entering the country
Remotely Delivered Weight-Loss Intervention Beneficial in Breast Cancer
Intervention induces significant weight loss across demographic and treatment factors in patients with breast cancer, BMI ≥27
New GLP-1 Pill Helps People Lose 23 Pounds in Study
The pill offers an alternative to injections, which some people find difficult or unpleasant.
Weight Loss Linked to Increase in Pregnancy Rates
For women with obesity, weight loss was associated with increase in total pregnancy rates and in pregnancy resulting from unassisted conception
New Weight Loss Pill From Eli Lilly Shows Promise in Early Study
Very Low-Calorie Diet Plus Exercise Does Not Reduce Hip Pain in OA
No reduction seen in hip pain, but improvement seen in most secondary outcomes among adults with hip osteoarthritis and overweight, obesity
Less Processed Diet May Be More Beneficial for Weight Loss
Findings seen compared with an ultra-processed diet that meets national dietary guidelines
Rebound Weight Gain Common After Discontinuing Antiobesity Medications
AOMs linked to significant weight regain at eight weeks after drug discontinuation compared with control group
ENDO: Older Age, Female Sex Tied to Greater Muscle Loss With Semaglutide
Higher protein intake may be protective against muscle loss, which is tied to less improvement in glucose homeostasis
Certain Factors May Predict Weight Fluctuations After GLP-1 Receptor Agonist Treatment
Longer treatment duration, using semaglutide, higher percentage body fat, and nondiabetic status may be associated with better weight reduction
